|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls000659849 |
| 003 |
SK-MaSNL |
| 005 |
20260304094014.0 |
| 008 |
250425c1998 xo 0 slo |
| 015 |
|
|
|a SNBRB1998/05-12963
|
| 035 |
|
|
|a CLN000012041
|
| 035 |
|
|
|a urn:nbn:sk:snk-ab6lvf
|
| 035 |
|
|
|a (uuid)2ac36fd9-83c4-405b-bc9f-6792368c60c1
|
| 035 |
|
|
|a (urnnbn)urn:nbn:sk:snk:ar-005gtp
|
| 035 |
|
|
|a (sysno)vtls000659849
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a slo
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 615.24
|2 1997
|
| 100 |
1 |
|
|a Pullmannová, Dana
|4 aut
|9 14190
|
| 245 |
1 |
0 |
|a Perorálne antidiabetikum Glipizid - novšie poznatky
|c Dana Pullmannová
|
| 300 |
|
|
|b Sch.
|
| 504 |
|
|
|a Res. angl. Bibliogr. odkazy
|
| 650 |
0 |
7 |
|a Glipizid (liek)
|2 snkbucl
|9 1389884
|
| 650 |
0 |
7 |
|a antidiabetiká
|2 snkbucl
|9 14191
|
| 650 |
0 |
7 |
|a glydiazínamid
|2 snkbucl
|9 1389885
|
| 655 |
|
7 |
|a články z novín a časopisov
|2 snkbucl
|9 267496
|
| 773 |
0 |
|
|t Lekársky obzor
|g Roč. 47, č. 5 (1998), s. 147-151
|x 0457-4214
|
| 850 |
|
|
|a Slovenská národná knižnica
|
| 852 |
|
|
|a Slovenská národná knižnica
|
| 954 |
|
|
|a odborná, vedecká literatúra pôvodná (slovenská)
|2 lita
|
| 958 |
|
|
|a article2022
|
| 958 |
|
|
|a OND
|
| 958 |
|
|
|a NB
|
| 958 |
|
|
|a EUIPO
|
| 992 |
|
|
|a RBX
|
| 999 |
|
|
|c 2825264
|d 2827194
|
